Link Pharma Chem Ltd

Link Pharma Chem Management Change

Link Pharma Chem Limited has announced the re-appointment of Rishikesh Thakur and Satish G Thakur as Executive Directors for a term of 36 months each.

Link Pharma Chem Annual General Meeting

Link Pharma Chem Ltd. held its 41st Annual General Meeting on August 20, 2026, where shareholders transacted various ordinary and special business items.

Link Pharma Chem Q1 FY27 Results: Net Profit ₹0.3 Cr, Down 25.0% YoY

Link Pharma Chem Ltd reported revenue from operations of ₹8.8 Cr (+12.8% YoY) and net profit of ₹0.3 Cr (-25.0% YoY) for Q1 FY27.

Key figure

Net profit ₹0.3 Cr · -25.0% YoY

Link Pharma Chem Other Announcement

Link Pharma Chem Ltd notified the exchange regarding the dispatch of letters to shareholders containing the web link for the Annual Report 2025-2026.

Link Pharma Chem Board Meeting Date

Link Pharma Chem Ltd has scheduled a board meeting for August 5, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.

Link Pharma Chem Annual General Meeting

Link Pharma Chem Ltd has issued a notice convening its 41st Annual General Meeting on August 20, 2026, to be held via video conferencing.

Link Pharma Chem Promoter Buying (Off-Market)

Link Pharma Chem disclosed an inter-se transfer of 92,808 shares among promoter group members due to family succession in its shareholding pattern filing.

Link Pharma Chem Other Announcement

Link Pharma Chem confirms non-applicability of SEBI's Related Party Transaction disclosure requirements. The company remains below prescribed paid-up capital and net worth thresholds for compliance.

Link Pharma Chem Management Change

Link Pharma Chem approved the re-appointment of Mr. Satish G. Thakur as Chairman and Whole-time Director. His three-year term commences on June 24, 2026.

Execution

3 years

Link Pharma Chem Financial Results

Link Pharma Chem Ltd reported audited financial results for the year ended March 31, 2026. The Board also approved several key auditor and director re-appointments.

Link Pharma Chem Q4 FY26 Results: Net Loss of ₹0.4 Cr, Loss Widens

Link Pharma Chem Ltd reported revenue from operations of ₹6.6 Cr (+3.1% YoY) and a net loss of ₹0.4 Cr for Q4 FY26.

Key figure

Net loss ₹0.4 Cr

Link Pharma Chem Financial Results

Link Pharma Chem reported total annual income of ₹27.63 Crore and net profit of ₹0.08 Crore. The board also approved re-appointing key directors for three-year terms.

Value

₹27.63 Cr

Link Pharma Chem Board Meeting Date

Link Pharma Chem scheduled a board meeting for May 21, 2026, to approve audited annual financial results. The trading window remains closed until May 23.

Link Pharma Chem Other Announcement

Link Pharma Chem Ltd submitted its quarterly confirmation certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The certificate, issued by MUFG Intime India, confirms the processing of dematerialisation requests and substitution of names in the register of members within prescribed timelines.